SCA's presentation at Handelsbanken Retail and Consumer Seminar in December 2012, held by Johan Karlsson, VP Investor Relations

1. Handelsbanken Retail and
Consumer Seminar
Johan Karlsson, Vice President Investor Relations

2. SCA Group
 Net sales of SEK 91bn*
 37,000 employees
 Sales in more than 100 countries
 Leading global hygiene company
 #1 or #2 positions in close to 80 countries
 Strong brands;
TEN and Tork are leading global billion-euro
brands for Incontinence care and AFH tissue
 Europe’s largest private forest owner
 Europe’s second-largest sawmill company
 Several of the world’s most prestigious
sustainability awards
* 2011 sales adjusted for closed transactions
2 December 2012

3. Transforming SCA
 Divestment of the Packaging business, excluding the two kraftliner mills
 Acquisition of Georgia-Pacific’s European tissue operations
 Acquisitions in emerging markets
 Everbeauty in Asia
 Pro Descart in Brazil
 San Saglik and Komili(50%) in Turkey
 Joint venture in Australia/New Zealand
 Divestment of Aylesford Newsprint
 Efficiency program
 Leadership and culture
3 December 2012

4. SCA Group
9 months 2012 sales and EBIT by Business Area
Sales by Business Area EBIT by Business Area
Forest Products Personal Care Forest Products Personal Care
22% 16%
30% 35%
48% 49%
Tissue Tissue
4 December 2012

5. SCA Group
Sales by Product Category
Personal Care Tissue
Feminine care
15% Incontinence products
AFH tissue
38%
54%
31% 62%
Baby diapers
73% branded
Consumer tissue
52% branded
5 December 2012

6. Leading Market positions
Globally and regionally
Value market positions
North America Nordic region
Incontinence products: 2 Incontinence products: 1 Europe
AFH tissue: 3 Tissue: 1
Baby diapers: 1
AFH tissue: 1 Incontinence products 1
Mexico Baby diapers: 3
Consumer tissue: 2
Incontinence products: 1 Feminine care 3
Feminine care 2
Feminine care: 1 Private forest owners: 1
Consumer tissue 2 Solid-wood products: 2
AFH tissue: 3
Baby diapers: 3
Asia
Incontinence products: 1
Colombia Globally
Incontinence products: 1
Incontinence products: 1
Feminine care: 1
AFH tissue: 1
Tissue: 1
Consumer tissue: 2
Baby diapers 2
6 December 2012

7. SCA Group’s Priorities
EFFICIENCY INNOVATION GROWTH
SUSTAINABILITY
7 December 2012

8. Efficiency
 Restructuring program in baby diapers
in Europe completed
 2011 Efficiency program
 Annual cost saving: EUR 80m
 Higher machine efficiency and reduced CAPEX
 Cost and productivity program
 Annual cost saving: EUR 300m
 Georgia-Pacific synergies
 Annual cost saving: EUR 125m
 Energy efficiency program
 Annual cost saving: EUR 70m
 Efficiency improvements in Forest Products
 Investments in upgrades and new capacity
8 December 2012

9. Cost and Productivity program*
Key actions
 Manufacturing
 Blueprint implementation Cost savings
 Asset utilization improvements
 Best practice sharing
SG&A
 Sourcing
 World-class sourcing processes Logistics 12%
 Leverage global scale 6% Manufacturing
 Consolidation of suppliers 43%
 Logistics
 Optimize warehouse footprint 39%
 Lower transportation costs
Sourcing
 Working capital management
 SG&A
 Fewer layers in the organization
 Clear roles and responsibilities, no overlaps
 Center-led support model
Total annual cost savings: EUR 300m
Related restructuring costs: EUR 100m
Headcount reduction: approx. 1,500
* Excluding Georgia-Pacific acquisition
9 December 2012

10. Georgia-Pacific Acquisition
Strengthens our no.1 position
 Perfect strategic fit
 Substantial synergies
 Strengthens our geographic presence in Europe
 Strong innovation portfolio
 Strengthens our branded portfolio
10 December 2012

11. Georgia-Pacific Acquisition
Synergies
Supply chain synergies
Cost synergies
Cost synergies
 Manufacturing excellence and best
practice
Support and
 Footprint optimization overhead
 Scale effects raw materials 25%
 Logistics optimization 60% Supply chain
15%
Sales and Marketing Sales and
Marketing
 S&M organization consolidation
 A&P efficiency
Support and overhead
 Consolidation of support functions
Total annual cost synergies: EUR 125m
Related restructuring costs: EUR 130m
11 December 2012

12. Innovation drives Profitable growth
Strengthens market positions and profitability
 Meet changing demands and requirements
 Create long-term, profitable differentiation
 Strengthen market positions
 Build stronger brands
 Drive growth
12 December 2012

13. Market Drivers
Good growth opportunities
 Global population growth
 An aging population
 Increased market penetration
 Higher disposable income
 Customers and consumers demand
more comfort and sustainability
13 December 2012

14. Global Hygiene Products Market
Increased penetration and aging and growing population
Personal Care
Tissue
2010 2017
14 December 2012

15. Hygiene Products
High potential in markets with low penetration
Usage of Hygiene products
Units/capita/year Units/child/year Units/woman/year Kg/capita/year
North America Western Europe Eastern Europe Latin America Asia
15 December 2012

16. Growth
High growth in Emerging markets
Q3 2012
Emerging markets sales growth:
Personal Care: +26%*
Tissue: +20%*
% of Personal Care sales** % of Tissue sales**
Emerging markets 16% Emerging markets
37%
Mature markets Mature markets
* Adjusted for exchange rate movements
** Q3 2012
16 December 2012

17. SCA’s Market Priority
Mature markets Established Not-present
 Improve profitability emerging markets emerging markets
 Increased cash flow  Profitable growth  Selected entry
generation  Strengthen market
 Strengthen market positions
positions  Category expansion
 Category expansion
17 December 2012

18. Financial Targets
Group
ROCE** 13%
Debt/Equity 0.70
Debt payment capacity above 35%
Dividend policy 1/3 of cash flow from current operations
Business areas
Sales growth* ROCE**
Personal Care 5-7% 30%
Tissue 3-4% 15%
Forest Products in line with market in top quartile
* Annual organic sales growth
** Return on capital employed
18 December 2012

19. IR Contacts:
Johan Karlsson, VP Investor Relations Louise Tjeder, Director Investor Relations
Tel: +46 8 788 51 30 Tel: +46 8 788 51 62
Email: ir@sca.com Website: www.sca.com